UTHR vs ZVRA · P/E 20, rev $1.56B vs P/E 6.3, rev $75.9M
United Therapeutics Corporation (UTHR) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
UTHR currently screens at market cap $23.41B and trailing P/E 20.4. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the UTHR and ZVRA stock pages for the full models.
Not investment advice.